{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:32:03Z","timestamp":1790188323257,"version":"4.1.0"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AA027396"],"award-info":[{"award-number":["AA027396"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["GM104323"],"award-info":[{"award-number":["GM104323"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["GM113228"],"award-info":[{"award-number":["GM113228"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01982","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T05:38:16Z","timestamp":1566452296000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":60,"title":["IL-17, IL-27, and IL-33: A Novel Axis Linked to Immunological Dysfunction During Sepsis"],"prefix":"10.3389","volume":"10","author":[{"given":"Kristen N.","family":"Morrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig M.","family":"Coopersmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy L.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/cc9031","article-title":"Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection","volume":"14","author":"Gogos","year":"2010","journal-title":"Crit Care."},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00024382-200116020-00001","article-title":"Sepsis syndromes: understanding the role of innate and acquired immunity","volume":"16","author":"Oberholzer","year":"2001","journal-title":"Shock"},{"key":"B3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/09680519010070020201","article-title":"Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review","volume":"7","author":"Cavaillon","year":"2001","journal-title":"J Endotoxin Res"},{"key":"B4","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V87.10.4261.bloodjournal87104261","article-title":"Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators","volume":"87","author":"Ayala","year":"1996","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1179\/096805106X102246","article-title":"Compartmentalization of the inflammatory response in sepsis and SIRS","volume":"12","author":"Cavaillon","year":"2006","journal-title":"J Endotoxin Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000102075","article-title":"Determining the degree of immunodysregulation in sepsis","volume":"156","author":"Cavaillon","year":"2007","journal-title":"Contrib Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11908-015-0487-4","article-title":"Sepsis in the severely immunocompromised patient","volume":"17","author":"Kalil","year":"2015","journal-title":"Curr Infect Dis Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1684\/ecn.2011.0281","article-title":"Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock","volume":"22","author":"Tamayo","year":"2011","journal-title":"Eur Cytokine Netw"},{"key":"B9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40635-014-0020-3","article-title":"Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach","volume":"2","author":"Cazalis","year":"2014","journal-title":"Intensive Care Med Exp"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1097\/CCM.0000000000002292","article-title":"An unbalanced inflammatory cytokine response is not associated with mortality following sepsis: a prospective cohort study","volume":"45","author":"Frencken","year":"2017","journal-title":"Crit Care Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.4049\/jimmunol.1201806","article-title":"Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis","volume":"189","author":"Osuchowski","year":"2012","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.cyto.2011.12.002","article-title":"A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis","volume":"57","author":"Andaluz-Ojeda","year":"2012","journal-title":"Cytokine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"98960","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"key":"B14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00068-017-0841-3","article-title":"Interleukin-17 as a predictor of sepsis in polytrauma patients: a prospective cohort study","volume":"44","author":"Ahmed Ali","year":"2018","journal-title":"Eur J Trauma Emerg Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"R254","DOI":"10.1186\/cc10515","article-title":"IL17A genetic variation is associated with altered susceptibility to Gram-positive infection and mortality of severe sepsis","volume":"15","author":"Nakada","year":"2011","journal-title":"Crit Care."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.4049\/jimmunol.0801162","article-title":"IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells","volume":"182","author":"Diveu","year":"2009","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ni0906-899","article-title":"All in the family: IL-27 suppression of T(H)-17 cells","volume":"7","author":"Colgan","year":"2006","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/ni1376","article-title":"Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system","volume":"7","author":"Stumhofer","year":"2006","journal-title":"Nat Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells","volume":"7","author":"Batten","year":"2006","journal-title":"Nat Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"R213","DOI":"10.1186\/cc11847","article-title":"Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children","volume":"16","author":"Wong","year":"2012","journal-title":"Crit Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/cc11893","article-title":"Interleukin-27: a potential new sepsis biomarker exposed through genome-wide transcriptional profiling","volume":"16","author":"Scicluna","year":"2012","journal-title":"Crit Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/SHK.0b013e3182a67632","article-title":"Interleukin 27 as a sepsis diagnostic biomarker in critically ill adults","volume":"40","author":"Wong","year":"2013","journal-title":"Shock"},{"key":"B23","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jcrc.2014.04.004","article-title":"Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults","volume":"29","author":"Wong","year":"2014","journal-title":"J Crit Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s13054-015-1095-2","article-title":"Interleukin-27: a novel biomarker in predicting bacterial infection among the critically ill","volume":"19","author":"Hanna","year":"2015","journal-title":"Crit Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2016.08.006","article-title":"Interleukin-27 is elevated in sepsis-induced myocardial dysfunction and mediates inflammation","volume":"88","author":"Gao","year":"2016","journal-title":"Cytokine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/SHK.0000000000000753","article-title":"Multiplex cytokine profiling identifies interleukin-27 as a novel biomarker for neonatal early onset sepsis","volume":"47","author":"He","year":"2017","journal-title":"Shock"},{"key":"B27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13054-018-2180-0","article-title":"The interleukin-27\u2212964A>G polymorphism enhances sepsis-induced inflammatory responses and confers susceptibility to the development of sepsis","volume":"22","author":"He","year":"2018","journal-title":"Crit Care"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.4049\/jimmunol.0900735","article-title":"Differential effect of IL-27 on developing versus committed Th17 cells","volume":"183","author":"El-behi","year":"2009","journal-title":"J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.4049\/jimmunol.0900568","article-title":"IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells","volume":"183","author":"Murugaiyan","year":"2009","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1089\/jir.2010.0115","article-title":"Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1","volume":"31","author":"Liu","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.4049\/jimmunol.1200141","article-title":"Independent and interdependent immunoregulatory effects of IL-27, IFN-beta, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis","volume":"190","author":"Fitzgerald","year":"2013","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1038\/emm.2013.89","article-title":"In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis","volume":"45","author":"Moon","year":"2013","journal-title":"Exp Mol Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.imlet.2013.05.001","article-title":"IL-27 suppresses the production of IL-22 in human CD4(+) T cells by inducing the expression of SOCS1","volume":"152","author":"Wang","year":"2013","journal-title":"Immunol Lett"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20060471","article-title":"Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27","volume":"203","author":"Wirtz","year":"2006","journal-title":"J Exp Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cyto.2010.04.015","article-title":"Interleukin-27 expression following infection with the murine gammaherpesvirus 68","volume":"51","author":"Nelson","year":"2010","journal-title":"Cytokine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/IAI.01091-13","article-title":"IL-27 receptor signaling regulates memory CD4+ T cell populations and suppresses rapid inflammatory responses during secondary malaria infection","volume":"82","author":"Gwyer Findlay","year":"2014","journal-title":"Infect Immun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1136\/thoraxjnl-2014-205777","article-title":"IL-27 controls sepsis-induced impairment of lung antibacterial host defence","volume":"69","author":"Cao","year":"2014","journal-title":"Thorax"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5668","DOI":"10.4049\/jimmunol.1302280","article-title":"Interruption of macrophage-derived IL-27(p28) production by IL-10 during sepsis requires STAT3 but not SOCS3","volume":"193","author":"Bosmann","year":"2014","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"i101","DOI":"10.1136\/annrheumdis-2011-200589","article-title":"IL-33: a Janus cytokine","volume":"71","author":"Liew","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nm.2156","article-title":"Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection","volume":"16","author":"Alves-Filho","year":"2010","journal-title":"Nat Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2015.11.009","article-title":"The immunoprotective activity of interleukin-33 in mouse model of cecal ligation and puncture-induced sepsis","volume":"169","author":"Li","year":"2016","journal-title":"Immunol Lett"},{"key":"B42","doi-asserted-by":"publisher","first-page":"14919","DOI":"10.1038\/ncomms14919","article-title":"IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population","volume":"8","author":"Nascimento","year":"2017","journal-title":"Nat Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ni.3308","article-title":"Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells","volume":"17","author":"Duerr","year":"2016","journal-title":"Nat Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ni.3309","article-title":"Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses","volume":"17","author":"Moro","year":"2016","journal-title":"Nat Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/mi.2016.20","article-title":"IL-27 suppresses type 2 immune responses in vivo via direct effects on group 2 innate lymphoid cells","volume":"9","author":"McHedlidze","year":"2016","journal-title":"Mucosal Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"510","DOI":"10.4049\/jimmunol.1601984","article-title":"STAT1 represses cytokine-producing group 2 and group 3 innate lymphoid cells during viral infection","volume":"199","author":"Stier","year":"2017","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/imcb.12159","article-title":"Interleukin-33 contributes to ILC2 activation and early inflammation-associated lung injury during abdominal sepsis","volume":"96","author":"Xu","year":"2018","journal-title":"Immunol Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.ajpath.2018.05.009","article-title":"Group 2 innate lymphoid cells (ILC2s) are key mediators of the inflammatory response in polymicrobial sepsis","volume":"188","author":"Chun","year":"2018","journal-title":"Am J Pathol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e124168","DOI":"10.1172\/jci.insight.124168","article-title":"Protection against Staphylococcus aureus bacteremia-induced mortality depends on ILC2s and eosinophils","volume":"4","author":"Krishack","year":"2019","journal-title":"JCI Insight"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.4049\/jimmunol.170.4.1958","article-title":"CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism","volume":"170","author":"Chung","year":"2003","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1096\/fj.07-105221","article-title":"Adverse functions of IL-17A in experimental sepsis","volume":"22","author":"Flierl","year":"2008","journal-title":"FASEB J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.4049\/jimmunol.0803039","article-title":"IL-17 receptor signaling is required to control polymicrobial sepsis","volume":"182","author":"Freitas","year":"2009","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jss.2010.11.901","article-title":"Interleukin-17A plays a pivotal role in polymicrobial sepsis according to studies using IL-17A knockout mice","volume":"174","author":"Ogiku","year":"2012","journal-title":"J Surg Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41467-019-08581-8","article-title":"Intestinal non-canonical NFkappaB signaling shapes the local and systemic immune response","volume":"10","author":"Ramakrishnan","year":"2019","journal-title":"Nat Commun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e1007099","DOI":"10.1371\/journal.ppat.1007099","article-title":"IL-17 can be protective or deleterious in murine pneumococcal pneumonia","volume":"14","author":"Ritchie","year":"2018","journal-title":"PLoS Pathog."},{"key":"B56","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/SHK.0000000000000207","article-title":"Elevated expression of IL-23\/IL-17 pathway-related mediators correlates with exacerbation of pulmonary inflammation during polymicrobial sepsis","volume":"42","author":"Cauvi","year":"2014","journal-title":"Shock"},{"key":"B57","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.imlet.2016.08.002","article-title":"Systemic over-release of interleukin-17 in acute kidney injury after septic shock: clinical and experimental evidence","volume":"178","author":"Maravitsa","year":"2016","journal-title":"Immunol Lett."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e46506","DOI":"10.1371\/journal.pone.0046506","article-title":"Neutralisation of peritoneal IL-17A markedly improves the prognosis of severe septic mice by decreasing neutrophil infiltration and proinflammatory cytokines","volume":"7","author":"Li","year":"2012","journal-title":"PLoS ONE"},{"key":"B59","doi-asserted-by":"publisher","first-page":"E2627","DOI":"10.1073\/pnas.1515793113","article-title":"Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18","volume":"113","author":"Wynn","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B60","doi-asserted-by":"publisher","first-page":"L1015","DOI":"10.1152\/ajplung.00158.2016","article-title":"IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumonia","volume":"311","author":"Wolf","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"15750","DOI":"10.1038\/s41598-018-34054-x","article-title":"The roles of IL-17C in T cell-dependent and -independent inflammatory diseases","volume":"8","author":"Yamaguchi","year":"2018","journal-title":"Sci Rep"},{"key":"B62","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.immuni.2011.09.010","article-title":"Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E","volume":"35","author":"Chang","year":"2011","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"key":"B64","doi-asserted-by":"publisher","first-page":"7684","DOI":"10.4049\/jimmunol.174.12.7684","article-title":"Positive and negative regulation of the IL-27 receptor during lymphoid cell activation","volume":"174","author":"Villarino","year":"2005","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.4049\/jimmunol.1103382","article-title":"IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells","volume":"188","author":"Matta","year":"2012","journal-title":"J Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ni.2695","article-title":"IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39","volume":"14","author":"Mascanfroni","year":"2013","journal-title":"Nat Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"43441","DOI":"10.1038\/srep43441","article-title":"Interleukin-27 enhances the potential of reactive oxygen species generation from monocyte-derived macrophages and dendritic cells by induction of p47(phox)","volume":"7","author":"Sowrirajan","year":"2017","journal-title":"Sci Rep"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e02196","DOI":"10.1128\/JVI.02196-17","article-title":"Interleukin-27R signaling mediates early viral containment and impacts innate and adaptive immunity after chronic lymphocytic choriomeningitis virus infection","volume":"92","author":"Harker","year":"2018","journal-title":"J Virol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e0201249","DOI":"10.1371\/journal.pone.0201249","article-title":"IL-27 regulates the number, function and cytotoxic program of antiviral CD4 T cells and promotes cytomegalovirus persistence","volume":"13","author":"Wehrens","year":"2018","journal-title":"PLoS ONE"},{"key":"B70","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00134-007-0968-5","article-title":"The human response to infection is associated with distinct patterns of interleukin 23 and interleukin 27 expression","volume":"34","author":"O'Dwyer","year":"2008","journal-title":"Intensive Care Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1002\/eji.201242526","article-title":"Production of interleukin-27 by human neutrophils regulates their function during bacterial infection","volume":"42","author":"Rinchai","year":"2012","journal-title":"Eur J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jhep.2015.12.020","article-title":"Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells","volume":"64","author":"Yan","year":"2016","journal-title":"J Hepatol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/ni1541","article-title":"A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells","volume":"8","author":"Awasthi","year":"2007","journal-title":"Nat Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.smim.2006.01.007","article-title":"Tr1 cells: from discovery to their clinical application","volume":"18","author":"Battaglia","year":"2006","journal-title":"Semin Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41586-018-0206-z","article-title":"Induction and transcriptional regulation of the co-inhibitory gene module in T cells","volume":"558","author":"Chihara","year":"2018","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/JLB.4A0718-292R","article-title":"Sepsis erodes CD8(+) memory T cell-protective immunity against an EBV homolog in a 2B4-dependent manner","volume":"105","author":"Xie","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e0211716","DOI":"10.1371\/journal.pone.0211716","article-title":"Sepsis induces long-lasting impairments in CD4+ T-cell responses despite rapid numerical recovery of T-lymphocyte populations","volume":"14","author":"Ammer-Herrmenau","year":"2019","journal-title":"PLoS ONE"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e0199497","DOI":"10.1371\/journal.pone.0199497","article-title":"Restoration of T cell function in multi-drug resistant bacterial sepsis after interleukin-7, anti-PD-L1, and OX-40 administration","volume":"13","author":"Thampy","year":"2018","journal-title":"PLoS ONE"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.4049\/jimmunol.1701618","article-title":"Sepsis-Induced T cell immunoparalysis: the ins and outs of impaired T cell immunity","volume":"200","author":"Jensen","year":"2018","journal-title":"J Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1073\/pnas.1816698116","article-title":"A folding switch regulates interleukin 27 biogenesis and secretion of its alpha-subunit as a cytokine","volume":"116","author":"Muller","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B81","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel \u2018alarmin'?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS ONE"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.4049\/jimmunol.1101977","article-title":"Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain","volume":"188","author":"Pichery","year":"2012","journal-title":"J Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/intimm\/dxr006","article-title":"Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation","volume":"23","author":"Louten","year":"2011","journal-title":"Int Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B86","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12929-018-0455-z","article-title":"IL-33 receptor (ST2) deficiency downregulates myeloid precursors, inflammatory NK and dendritic cells in early phase of sepsis","volume":"25","author":"Babic","year":"2018","journal-title":"J Biomed Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1159\/000479836","article-title":"IL-33 attenuates sepsis by inhibiting IL-17 receptor signaling through upregulation of SOCS3","volume":"42","author":"Lv","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.immuni.2012.03.024","article-title":"Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1","volume":"36","author":"Hirahara","year":"2012","journal-title":"Immunity"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.ajpath.2014.02.004","article-title":"IL-27R-mediated regulation of IL-17 controls the development of respiratory syncytial virus-associated pathogenesis","volume":"184","author":"de Almeida Nagata","year":"2014","journal-title":"Am J Pathol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.4049\/jimmunol.1302246","article-title":"IL-27 induces Th17 differentiation in the absence of STAT1 signaling","volume":"195","author":"Peters","year":"2015","journal-title":"J Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1002\/eji.201344360","article-title":"Committed Tc17 cells are phenotypically and functionally resistant to the effects of IL-27","volume":"44","author":"El-Behi","year":"2014","journal-title":"Eur J Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/eji.201141947","article-title":"IL-33 attenuates EAE by suppressing IL-17 and IFN-gamma production and inducing alternatively activated macrophages","volume":"42","author":"Jiang","year":"2012","journal-title":"Eur J Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"iii29","DOI":"10.1136\/ard.2007.078337","article-title":"New therapies for sepsis: focus on the interleukin (IL)12 family member IL27","volume":"66","author":"Neurath","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2001-1326-1-4","article-title":"Therapeutic potential of targeting IL-17 and IL-23 in sepsis","volume":"1","author":"Bosmann","year":"2012","journal-title":"Clin Transl Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1128\/IAI.02908-14","article-title":"Crucial and diverse role of the interleukin-33\/ST2 axis in infectious diseases","volume":"83","author":"Rostan","year":"2015","journal-title":"Infect Immun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01982\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T18:07:18Z","timestamp":1575569238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01982\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":95,"alternative-id":["10.3389\/fimmu.2019.01982"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01982","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"article-number":"1982"}}